Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
Early Prospective Therapy Trial to Delay Renal Failure in Children With Alport Syndrome
Sponsor: German Federal Ministry of Education and Research
This PHASE3 trial investigates Renal Insufficiency, Chronic and is currently completed. German Federal Ministry of Education and Research leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 5 earlier versions
-
Feb 2020 — Jul 2020 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Nov 2019 — Feb 2020 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Nov 2017 [monthly]
Recruiting PHASE3
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- German Federal Ministry of Education and Research
- Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- University Medical Center Goettingen
For direct contact, visit the study record on ClinicalTrials.gov .